ArticleAmerican journal of respiratory and critical care medicine2021
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.European respiratory review : an official journal of the European Respiratory Society · 2026Pooled it
- Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.Journal of the American Heart Association · 2024Pooled it
- Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension.Respiratory medicine · 2022Trial
- Article
- Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis.JHLT open · 2026Article
- Safety and efficacy of upfront triple therapy including parenteral treprostinil compared to double oral therapy in PAH (TripleTRE): study protocol for a randomised trial.ERJ open research · 2026Article
- Tadalafil plus endothelin receptor antagonists in connective tissue disease-associated pulmonary arterial hypertension: A multicenter study on exercise capacity and cardiac outcomes.Rheumatology and immunology research · 2025Article
- Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research.Pulmonary circulation · 2025Article
- Pulmonary arterial hypertension in Latin America. The age and comorbidity paradox.International journal of cardiology. Congenital heart disease · 2025Review
- The effects of bolus isosorbide dinitrate on pulmonary hypertension with cardiopulmonary comorbidities.Heart and vessels · 2025Article
- Treatment algorithm for pulmonary arterial hypertension.The European respiratory journal · 2024Review
- Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.ESC heart failure · 2024Article
- Neutrophil extracellular traps promote proliferation of pulmonary smooth muscle cells mediated by CCDC25 in pulmonary arterial hypertension.Respiratory research · 2024Article
- Contribution of pressure and flow changes to resistance reduction after pulmonary arterial hypertension treatment: a meta-analysis of 3898 patients.ERJ open research · 2024Article
- Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing.Journal of clinical medicine · 2023Article
- Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry.Respiratory research · 2023Article
- Pulmonary Hypertension: A Contemporary Review.American journal of respiratory and critical care medicine · 2023Review
- Review
- Article
- Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials.Annals of the American Thoracic Society · 2023Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
26 authors.
Roberto BadagliaccaDepartment of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.
Michele D'AltoDepartment of Cardiology, Monaldi Hospital, University L. Vanvitelli, Naples, Italy.
Stefano GhioFondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S Matteo, Pavia, Italy.
Paola ArgientoDepartment of Cardiology, Monaldi Hospital, University L. Vanvitelli, Naples, Italy.
Vincenzo BellomoDepartment of Cardiology, F.Miulli Hospital, Acquaviva delle Fonti, Bari, Italy.
Natale Daniele BrunettiDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Gavino CasuAzienda per la Tutela della Salute Sardegna-Area Socio Sanitaria Locale Nuoro, San Francesco Hospital, Nuoro, Italy.
Marco ConfalonieriPulmonology Unit, Heart-Thorax-Vessels Department, University Hospital of Cattinara, Trieste, Italy.
Marco CordaAzienda Ospedaliera G. Brotzu San Michele, Cagliari, Italy.
Michele CorrealeCardiology Department, Ospedali Riuniti University Hospital, Foggia, Italy.
Carlo D'AgostinoCardiology Department, University Hospital Policlinico Consorziale Bari, Italy.
Lucrezia De MicheleCardiology Department, University Hospital Policlinico Consorziale Bari, Italy.
Giuseppe GalganoDepartment of Cardiology, F.Miulli Hospital, Acquaviva delle Fonti, Bari, Italy.
Alessandra GrecoFondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S Matteo, Pavia, Italy.
Carlo LombardiCardiologia, Università degli studi di Brescia, Brescia, Italy.
Giovanna ManziDepartment of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.
Valentina MercurioDepartment of Translational Medical Sciences, Federico II University of Naples, Naples, Italy.
Massimiliano MulèFerrarotto Hospital, Catania, Italy.
Giuseppe PacioccoDipartimento Cardio-Toraco-Vascolare, Clinica Pneumologica, Azienda Ospedaliera San Gerardo, Monza, Italy.
Silvia PapaDepartment of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.
Emanuele RomeoDepartment of Cardiology, Monaldi Hospital, University L. Vanvitelli, Naples, Italy.
Laura ScelsiFondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S Matteo, Pavia, Italy.
Davide StolfoCardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.
Patrizio VituloPulmonology Unit, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Mediterraneo Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy; and.
Robert NaeijeDepartment of Pathophysiology, Free University of Brussels, Brussels, Belgium.
Carmine Dario VizzaDepartment of Cardiovascular and Respiratory Sciences, Sapienza University of Rome, Rome, Italy.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Administration, OralAgedAged, 80 and overAntihypertensive AgentsDrug CombinationsEndothelin Receptor AntagonistsFemaleHemodynamicsHumansMaleMiddle AgedPhosphodiesterase 5 InhibitorsPulmonary Arterial HypertensionRisk Reduction BehaviorTreatment OutcomeVascular ResistanceAntihypertensive AgentsDrug CombinationsEndothelin Receptor AntagonistsPhosphodiesterase 5 Inhibitorsechocardiographypulmonary arterial hypertensionpulmonary vascular resistanceright heart remodelingupfront therapy
Identifiers
PMID
32857597What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.